4-[(4-Chloro-2-pyrimidinyl)amino]-benzonitrile | CAS:244768-32-9 99.0% bulk supply

We serve 4-[(4-Chloro-2-pyrimidinyl)amino]-benzonitrile CAS:244768-32-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Chemical Name:4-[(4-Chloro-2-pyrimidinyl)amino]-benzonitrile

CAS.NO:244768-32-9

Synonyms:4-[(4-Chloro-2-pyrimidinyl)amino]-benzonitrile

4-[(4-chloropyrimidin-2-yl)amino]benzonitrile

4-[(4-Chloropyrimidin-2-yl)amino]benzonitrile

4-[(4-Chloro-2-pyrimidinyl)amino]benzonitrile

Physical and Chemical Properties:

Density 1.4±0.1 g/cm3

Boiling Point 441.0±51.0 °C at 760 mmHg

Molecular Formula C11H7ClN4

Molecular Weight 230.653

Flash Point 220.5±30.4 °C

Specification:

Appearance:White to yellow powder

Assay(HPLC):≥99.0%

Any single inpurity:≤0.5%

Moisutre:≤0.5%

Sulfated Ashes:≤0.3%

Packing:25 kg/drum, can also be packaged according to customer requirements

Storage:Store in a cool, ventilated place

Application:Intermediate of Rilpivirine(CAS:500287-72-9).

Contact us for information like 4-[(4-Chloro-2-pyrimidinyl)amino]-benzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-[(4-Chloro-2-pyrimidinyl)amino]benzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[(4-Chloropyrimidin-2-yl)amino]benzonitrile Use and application,4-[(4-Chloro-2-pyrimidinyl)amino]benzonitrile technical grade,usp/ep/jp grade.

Related News: With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.6-chloro-7H-purine manufacturer The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.2,6-Dichlorobenzoxazole supplier The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.7-amino-3-[(Z)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid vendor The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.As many as 9,000 medical workers in Hong Kong have pledged to strike this week, a threat that alarms the territory’s officials as they are struggling to contain the coronavirus outbreak.